EFTR
Effector Therapeutics Inc
NASDAQ: EFTR · HEALTHCARE · BIOTECHNOLOGY
$0.00
+0.00% today
Updated 2026-04-30
Market cap
$940.00
P/E ratio
—
P/S ratio
69.65x
EPS (TTM)
$-12.57
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Effector Therapeutics Inc (EFTR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-947.00%
ROA
-83.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-29.74M | — | — | — |
| 2020 | $42.00M | $14.21M | 100.00% | 37.66% | 33.84% |
| 2021 | $1.43M | $15.80M | 100.00% | -2,230.56% | 1,104.76% |
| 2022 | $3.55M | $-12.93M | 98.51% | -911.99% | -363.83% |
| 2023 | $0.00 | $-35.81M | — | — | — |